These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 11257700

  • 1. Treatment of human renal cell carcinoma by a conditionally replicating herpes vector G207.
    Oyama M, Ohigashi T, Hoshi M, Murai M, Uyemura K, Yazaki T.
    J Urol; 2001 Apr; 165(4):1274-8. PubMed ID: 11257700
    [Abstract] [Full Text] [Related]

  • 2. Oncolytic viral therapy for human prostate cancer by conditionally replicating herpes simplex virus 1 vector G207.
    Oyama M, Ohigashi T, Hoshi M, Murai M, Uyemura K, Yazaki T.
    Jpn J Cancer Res; 2000 Dec; 91(12):1339-44. PubMed ID: 11123435
    [Abstract] [Full Text] [Related]

  • 3. Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.
    Toda M, Rabkin SD, Martuza RL.
    Hum Gene Ther; 1998 Oct 10; 9(15):2177-85. PubMed ID: 9794202
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.
    Nakano K, Todo T, Chijiiwa K, Tanaka M.
    Mol Ther; 2001 Apr 10; 3(4):431-7. PubMed ID: 11319903
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
    Chahlavi A, Todo T, Martuza RL, Rabkin SD.
    Neoplasia; 1999 Jun 10; 1(2):162-9. PubMed ID: 10933051
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates.
    Varghese S, Newsome JT, Rabkin SD, McGeagh K, Mahoney D, Nielsen P, Todo T, Martuza RL.
    Hum Gene Ther; 2001 May 20; 12(8):999-1010. PubMed ID: 11387063
    [Abstract] [Full Text] [Related]

  • 12. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T, Martuza RL, Dallman MJ, Rabkin SD.
    Cancer Res; 2001 Jan 01; 61(1):153-61. PubMed ID: 11196154
    [Abstract] [Full Text] [Related]

  • 13. Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.
    Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL.
    Cancer Gene Ther; 2000 Feb 01; 7(2):275-83. PubMed ID: 10770637
    [Abstract] [Full Text] [Related]

  • 14. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
    Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M.
    J Gene Med; 2005 May 01; 7(5):638-48. PubMed ID: 15754306
    [Abstract] [Full Text] [Related]

  • 15. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
    Todo T, Martuza RL, Rabkin SD, Johnson PA.
    Proc Natl Acad Sci U S A; 2001 May 22; 98(11):6396-401. PubMed ID: 11353831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1.
    Yazaki T, Manz HJ, Rabkin SD, Martuza RL.
    Cancer Res; 1995 Nov 01; 55(21):4752-6. PubMed ID: 7585498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.